The question of how lifestyle, environment and genetics impact health and disease will soon be under the microscope. The National Institutes of Health recently announced $55 million in funding to launch a million-person study into the merits of precision medicine – the practice of shaping disease prevention and treatment to match a patient’s unique DNA. It’s part of President Obama’s Precision Medicine Initiative (PMI) Cohort Program, and Mayo Clinic will play an important role by housing the national biobank repository of research samples.
Precision medicine is being hailed as a way to transform health care by more accurately diagnosing disease and delivering safer therapies. That could mean a higher quality of care at a lower cost by eliminating unnecessary tests and procedures. The goal of the White House PMI Cohort is to eventually apply this individualized medicine to all genetic-based diseases.
For a better understanding of what Mayo Clinic's Biobank does, Jeff Olsen takes you inside in this Mayo Clinic Minute.
Journalists: Broadcast-quality video pkg (1:02) is in the downloads. Read the script.